Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review

Migraine, a commonly occurring neurological disorder, disproportionately affects women during their reproductive years, and its symptoms are often intensified by hormonal fluctuations. This narrative review examines the impact of hormonal contraceptives, particularly combined oral contraceptives (CO...

Full description

Saved in:
Bibliographic Details
Main Authors: Yethindra Vityala, Ruchika Garg, Samina Ausvi, Manjula Shantaram, Srikanya Tippabathini, Lekhashree Hosur Brahmananda Reddy, Yash Jain, Pavani Jaladi, Sai Praneeth Duvvuri, Krishna Chaitanya Meduri
Format: Article
Language:English
Published: Open Exploration 2024-09-01
Series:Exploration of Drug Science
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A100867/100867.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199609524256768
author Yethindra Vityala
Ruchika Garg
Samina Ausvi
Manjula Shantaram
Srikanya Tippabathini
Lekhashree Hosur Brahmananda Reddy
Yash Jain
Pavani Jaladi
Sai Praneeth Duvvuri
Krishna Chaitanya Meduri
author_facet Yethindra Vityala
Ruchika Garg
Samina Ausvi
Manjula Shantaram
Srikanya Tippabathini
Lekhashree Hosur Brahmananda Reddy
Yash Jain
Pavani Jaladi
Sai Praneeth Duvvuri
Krishna Chaitanya Meduri
author_sort Yethindra Vityala
collection DOAJ
description Migraine, a commonly occurring neurological disorder, disproportionately affects women during their reproductive years, and its symptoms are often intensified by hormonal fluctuations. This narrative review examines the impact of hormonal contraceptives, particularly combined oral contraceptives (COCs), on menstrual migraine (MM). This review assessed the impact of COCs on MM through a literature search in PubMed, Google Scholar, Web of Science, and Scopus using keywords like “menstrual migraine”, “hormone therapy”, and “COCs”. The selection criteria were peer-reviewed studies published between 2014 and 2024, written in English, and focused on MM treatment with COCs. Exclusion criteria were duplicates, editorials, irrelevant articles, and non-English studies. The literature reveals inconsistent results, with some studies reporting aggravation of migraine symptoms with COC use, whereas others indicate a decrease in the frequency and severity of attacks, especially with continuous use. Factors affecting these outcomes include patient age, menstrual cycle characteristics, and migraine type. It is crucial to choose contraceptives that suit individual patient profiles, considering the potential for increased migraine frequency or onset of migraine with aura in some women. Further studies are required to establish clear clinical guidelines. It is recommended to create personalized treatment plans that balance the effectiveness of migraine management with the overall health risks.
format Article
id doaj-art-c65371422d91459fb1ac1be57f5ccb1b
institution Kabale University
issn 2836-7677
language English
publishDate 2024-09-01
publisher Open Exploration
record_format Article
series Exploration of Drug Science
spelling doaj-art-c65371422d91459fb1ac1be57f5ccb1b2025-02-08T03:29:23ZengOpen ExplorationExploration of Drug Science2836-76772024-09-012666667610.37349/eds.2024.00067Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative reviewYethindra Vityala0https://orcid.org/0000-0003-1007-2422Ruchika Garg1Samina Ausvi2https://orcid.org/0000-0002-2308-5081Manjula Shantaram3https://orcid.org/0000-0002-3874-4465Srikanya Tippabathini4Lekhashree Hosur Brahmananda Reddy5Yash Jain6Pavani Jaladi7Sai Praneeth Duvvuri8https://orcid.org/0009-0007-2337-9219Krishna Chaitanya Meduri9https://orcid.org/0000-0001-8810-7299Honorary International Faculty, AJ Institute of Medical Sciences and Research Centre, Mangalore 575004, Karnataka, IndiaDepartment of Obstetrics and Gynecology, SN Medical College, Agra 282002, Uttar Pradesh, IndiaDepartment of Community Medicine, Viswabharathi Medical College, Kurnool 518467, Andhra Pradesh, IndiaChief of Research Centre, AJ Institute of Medical Sciences and Research Centre, Mangalore 575004, Karnataka, IndiaDepartment of Quality Control, K.C. Reddy Institute of Pharmaceutical Sciences, Guntur 522348, Andhra Pradesh, IndiaDepartment of Pharmacy Practice, SJM College of Pharmacy, Chitradurga 577501, Karnataka, IndiaDepartment of General Medicine, Shri Sanwaliya Ji Rajkiya Samanya Chikitsalay, Chittorgarh 312001, Rajasthan, IndiaDepartment of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education and Research, Anantapur 515721, Andhra Pradesh, IndiaDepartment of General Medicine, Maheshwara Medical College and Hospital, Hyderabad 502307, Telangana, IndiaDepartment of General Medicine, Maheshwara Medical College and Hospital, Hyderabad 502307, Telangana, IndiaMigraine, a commonly occurring neurological disorder, disproportionately affects women during their reproductive years, and its symptoms are often intensified by hormonal fluctuations. This narrative review examines the impact of hormonal contraceptives, particularly combined oral contraceptives (COCs), on menstrual migraine (MM). This review assessed the impact of COCs on MM through a literature search in PubMed, Google Scholar, Web of Science, and Scopus using keywords like “menstrual migraine”, “hormone therapy”, and “COCs”. The selection criteria were peer-reviewed studies published between 2014 and 2024, written in English, and focused on MM treatment with COCs. Exclusion criteria were duplicates, editorials, irrelevant articles, and non-English studies. The literature reveals inconsistent results, with some studies reporting aggravation of migraine symptoms with COC use, whereas others indicate a decrease in the frequency and severity of attacks, especially with continuous use. Factors affecting these outcomes include patient age, menstrual cycle characteristics, and migraine type. It is crucial to choose contraceptives that suit individual patient profiles, considering the potential for increased migraine frequency or onset of migraine with aura in some women. Further studies are required to establish clear clinical guidelines. It is recommended to create personalized treatment plans that balance the effectiveness of migraine management with the overall health risks.https://www.explorationpub.com/uploads/Article/A100867/100867.pdfmenstrual migrainehormone therapycombined oral contraceptivesmigraine with aura
spellingShingle Yethindra Vityala
Ruchika Garg
Samina Ausvi
Manjula Shantaram
Srikanya Tippabathini
Lekhashree Hosur Brahmananda Reddy
Yash Jain
Pavani Jaladi
Sai Praneeth Duvvuri
Krishna Chaitanya Meduri
Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
Exploration of Drug Science
menstrual migraine
hormone therapy
combined oral contraceptives
migraine with aura
title Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
title_full Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
title_fullStr Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
title_full_unstemmed Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
title_short Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
title_sort effect of combined oral contraceptives on menstrual migraine frequency and severity a narrative review
topic menstrual migraine
hormone therapy
combined oral contraceptives
migraine with aura
url https://www.explorationpub.com/uploads/Article/A100867/100867.pdf
work_keys_str_mv AT yethindravityala effectofcombinedoralcontraceptivesonmenstrualmigrainefrequencyandseverityanarrativereview
AT ruchikagarg effectofcombinedoralcontraceptivesonmenstrualmigrainefrequencyandseverityanarrativereview
AT saminaausvi effectofcombinedoralcontraceptivesonmenstrualmigrainefrequencyandseverityanarrativereview
AT manjulashantaram effectofcombinedoralcontraceptivesonmenstrualmigrainefrequencyandseverityanarrativereview
AT srikanyatippabathini effectofcombinedoralcontraceptivesonmenstrualmigrainefrequencyandseverityanarrativereview
AT lekhashreehosurbrahmanandareddy effectofcombinedoralcontraceptivesonmenstrualmigrainefrequencyandseverityanarrativereview
AT yashjain effectofcombinedoralcontraceptivesonmenstrualmigrainefrequencyandseverityanarrativereview
AT pavanijaladi effectofcombinedoralcontraceptivesonmenstrualmigrainefrequencyandseverityanarrativereview
AT saipraneethduvvuri effectofcombinedoralcontraceptivesonmenstrualmigrainefrequencyandseverityanarrativereview
AT krishnachaitanyameduri effectofcombinedoralcontraceptivesonmenstrualmigrainefrequencyandseverityanarrativereview